Comparison of pelvic floor muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: a randomized pilot study

Neurourology and Urodynamics
D McClurgA S Lowe-Strong

Abstract

Bladder dysfunction affects up to 90% of the multiple sclerosis (MS) population. Interventions such as Pelvic Floor Training and Advice (PFTA), Electromyography (EMG) Biofeedback, and Neuromuscular Electrical Stimulation (NMES) have received limited research attention within this population. This study aimed to determine the effectiveness of a combined programme of PFTA, EMG Biofeedback, and NMES for bladder dysfunction in MS. Females (n = 30) who fulfilled strict inclusion/exclusion criteria were recruited. Outcome measures (weeks 0, 9, 16, and 24) included: 3-day Voiding Diary; 24 hr Pad-Test; Uroflowmetry; Pelvic Floor Muscle Assessment; Incontinence Impact Questionnaire (IIQ); Urogenital Distress Inventory (UDI); King's Health Questionnaire (KHQ), and the Multiple Sclerosis Quality of Life-54 Instrument (MSQoL-54). Following baseline (week 0) assessment, participants were randomly allocated, under double blind conditions, to one of the three groups: Group 1 (PFTA); Group 2 (PFTA and EMG Biofeedback); and Group 3 (PFTA, EMG Biofeedback, and NMES). Treatment was for 9 weeks. Baseline severity (measured by number of leaks and pad weight) showed some variation between groups, although not statistically significant (P > 0.05); w...Continue Reading

Associated Clinical Trials

References

Apr 1, 1984·The Journal of Urology·M Fall
Jun 1, 1995·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·B G VickreyG W Ellison
Oct 1, 1994·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·S A ShumakerJ A Fantl
Mar 1, 1994·Gut·J S JamesonM Swash
Dec 1, 1995·Archives of Physical Medicine and Rehabilitation·G W FriedW E Staas
Jan 1, 1996·Journal of the Neurological Sciences·B Sharrack, R A Hughes
Aug 1, 1997·Clinical Rehabilitation·T VahteraJ Ruutiainen
Jan 9, 1998·British Journal of Obstetrics and Gynaecology·C J KelleherS Salvatore
May 20, 1998·Neurourology and Urodynamics·G LoseA Mattiasson
Dec 24, 1998·JAMA : the Journal of the American Medical Association·K L BurgioD Candib
Feb 22, 2001·Urology·S J CiancioT B Boone
Apr 12, 2002·Neurourology and Urodynamics·Werner SchäferUNKNOWN International Continence Society
Feb 1, 2003·Urology·Paul AbramsUNKNOWN Standardisation Sub-Committee of the International Continence Society
Nov 5, 2003·Gastroenterology·Christine NortonMichael A Kamm
Feb 26, 2004·JAMA : the Journal of the American Medical Association·Jayna M Holroyd-Leduc, Sharon E Straus

❮ Previous
Next ❯

Citations

Sep 29, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·A GhezziUNKNOWN Multiple Sclerosis Study Group, Italian Society of Neurology
Jul 18, 2008·Obstetrical & Gynecological Survey·Stergios K DoumouchtsisMichelle Fynes
Sep 15, 2012·Biologics : Targets & Therapy·Aziz Gulamhusein, Altaf Mangera
Feb 25, 2014·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·L GaspardC Detrembleur
Dec 12, 2012·Autoimmune Diseases·Angela SendersLynne Shinto
Dec 18, 2008·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Giulio Del PopoloGiuseppe Lombardi
Dec 18, 2008·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Roberta Motta, Maria Laura Lopes de Carvalho
Jun 24, 2010·Expert Opinion on Drug Safety·Richard NicholasTim Friede
May 25, 2013·Current Medical Research and Opinion·G SiracusaV L Lentini
Jun 22, 2013·Disease-a-month : DM·Peter K Sand, Robert I Sand
Jan 21, 2016·Lower Urinary Tract Symptoms·Satoru TakahashiMasayasu Koyama
Oct 20, 2010·The Urologic Clinics of North America·John T Stoffel
Aug 26, 2015·European Urology·Jan GroenBertil Blok
May 1, 2009·European Urology·Manfred StöhrerJean-Jacques Wyndaele
Apr 4, 2009·Complementary Therapies in Clinical Practice·Gil RavivAnat Achiron
Oct 27, 2010·Neurourology and Urodynamics·Adélia Correia LúcioCarlos Arturo Levi D'ancona
Apr 1, 2016·Nature Reviews. Urology·Véronique PhéJalesh N Panicker
Sep 1, 2015·Archives of Physical Medicine and Rehabilitation·David A GinsbergThomas K Watanabe
May 31, 2015·Current Urology Reports·Areeba Sadiq, Benjamin M Brucker
Jun 13, 2015·Lancet Neurology·Jalesh N PanickerThomas M Kessler
Dec 10, 2016·The Cochrane Database of Systematic Reviews·Fiona StewartJoao L Amaro
Jul 8, 2011·The Cochrane Database of Systematic Reviews·Roselien HerderscheeMaas Jan Heineman
Feb 26, 2014·Female Pelvic Medicine & Reconstructive Surgery·Cécile A UngerMatthew D Barber
Dec 15, 2015·Lower Urinary Tract Symptoms·Tomonori YamanishiTomoyuki Uchiyama
Oct 9, 2015·Neurourology and Urodynamics·Marianna Carvalho E Souza Leão CavalcantiMaria Helena Baena de Moraes Lopes
Jul 27, 2017·Journal of Physical Therapy Science·Carla Maria de Abreu PereiraKarina Tamy Kasawara
Jul 4, 2020·International Neurourology Journal·Riccardo BientinesiPierFrancesco Bassi
Mar 26, 2016·Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society·Adélia LúcioMaria Helena Baena de Moraes Lopes
Dec 31, 2014·Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society·Maria Carolina PerissinottoAnelyssa Abreu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.